1-20 of 54
Category: Editor's Choice
Journal Article
EDITOR'S CHOICE
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 3, May 2025, Pages 292–317, https://doi.org/10.1093/ehjcvp/pvaf012
Published: 08 March 2025
Journal Article
EDITOR'S CHOICE
Effect of SGLT2i on kidney outcomes of individuals with type 2 diabetes according to body mass index: nationwide cohort study
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 2, March 2025, Pages 155–163, https://doi.org/10.1093/ehjcvp/pvae094
Published: 03 February 2025
Journal Article
EDITOR'S CHOICE
Incidence and outcomes of transient new-onset atrial fibrillation complicating acute coronary syndromes: results from a systematic review and meta-analysis
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 8, December 2024, Pages 652–661, https://doi.org/10.1093/ehjcvp/pvae066
Published: 30 October 2024
Journal Article
EDITOR'S CHOICE
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 7, November 2024, Pages 614–645, https://doi.org/10.1093/ehjcvp/pvae064
Published: 05 September 2024
Journal Article
EDITOR'S CHOICE
The four-item PRECISE-DAPT score identifies coronary artery bypass grafting patients with increased risk for post-discharge major bleeding
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 1, January 2025, Pages 48–56, https://doi.org/10.1093/ehjcvp/pvae060
Published: 20 August 2024
Journal Article
EDITOR'S CHOICE
Pharmacological management of transthyretin amyloid cardiomyopathy: a scoping review
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 6, September 2024, Pages 547–556, https://doi.org/10.1093/ehjcvp/pvae044
Published: 03 June 2024
Journal Article
EDITOR'S CHOICE
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 3, April 2024, Pages 219–244, https://doi.org/10.1093/ehjcvp/pvae013
Published: 20 February 2024
Journal Article
EDITOR'S CHOICE
Effectiveness and safety of direct oral anticoagulation vs. warfarin in frail patients with atrial fibrillation
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 2, March 2024, Pages 137–146, https://doi.org/10.1093/ehjcvp/pvad091
Published: 22 November 2023
Journal Article
EDITOR'S CHOICE
A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 1, January 2024, Pages 35–44, https://doi.org/10.1093/ehjcvp/pvad073
Published: 06 October 2023
Journal Article
EDITOR'S CHOICE
The effect of SGLT2 inhibitors on the endothelium and the microcirculation: from bench to bedside and beyond
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 8, December 2023, Pages 741–757, https://doi.org/10.1093/ehjcvp/pvad053
Published: 27 July 2023
Journal Article
EDITOR'S CHOICE
Bleeding risk and P2Y12 inhibitors in all-comer patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: a single-centre cohort study
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 7, November 2023, Pages 617–626, https://doi.org/10.1093/ehjcvp/pvad048
Published: 04 July 2023
Journal Article
EDITOR'S CHOICE
Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease?
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 6, September 2023, Pages 570–582, https://doi.org/10.1093/ehjcvp/pvad044
Published: 16 June 2023
Journal Article
EDITOR'S CHOICE
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 462–496, https://doi.org/10.1093/ehjcvp/pvad032
Published: 29 April 2023
Journal Article
EDITOR'S CHOICE
The efficacy of PCSK9 inhibitors on major cardiovascular events and lipid profile in patients with diabetes: a systematic review and meta-analysis of randomized controlled trials
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 4, June 2023, Pages 318–327, https://doi.org/10.1093/ehjcvp/pvad019
Published: 27 March 2023
Journal Article
EDITOR'S CHOICE
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 3, April 2023, Pages 271–290, https://doi.org/10.1093/ehjcvp/pvad016
Published: 03 March 2023
Journal Article
EDITOR'S CHOICE
RNA-targeted therapeutics in cardiovascular disease: the time is now
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 1, January 2023, Pages 94–99, https://doi.org/10.1093/ehjcvp/pvac052
Published: 22 September 2022
Journal Article
EDITOR'S CHOICE
Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 2, March 2023, Pages 138–147, https://doi.org/10.1093/ehjcvp/pvac049
Published: 14 September 2022
Journal Article
EDITOR'S CHOICE
Photoinduced skin reactions of cardiovascular drugs—a systematic review
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 4, July 2022, Pages 420–430, https://doi.org/10.1093/ehjcvp/pvac017
Published: 12 March 2022
Journal Article
EDITOR'S CHOICE
SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 6, October 2022, Pages 557–567, https://doi.org/10.1093/ehjcvp/pvac001
Published: 11 January 2022
Journal Article
EDITOR'S CHOICE
Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 8, December 2022, Pages 756–767, https://doi.org/10.1093/ehjcvp/pvab079
Published: 22 November 2021
